| pubmed-article:20631 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20631 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:20631 | lifeskim:mentions | umls-concept:C0014792 | lld:lifeskim |
| pubmed-article:20631 | lifeskim:mentions | umls-concept:C0000530 | lld:lifeskim |
| pubmed-article:20631 | lifeskim:mentions | umls-concept:C1998793 | lld:lifeskim |
| pubmed-article:20631 | lifeskim:mentions | umls-concept:C0871161 | lld:lifeskim |
| pubmed-article:20631 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:20631 | pubmed:dateCreated | 1977-11-30 | lld:pubmed |
| pubmed-article:20631 | pubmed:abstractText | A 250,000-fold purification of pyrimidine 5'-nucleotidase from human erythrocytes has been achieved using a combination of DEAE-cellulose chromatography, ammonium sulfate fractionation, gel filtration, and isoelectric focusing. Polyacrylamide disc and starch gel electrophoresis of the purified material show two strong protein bands. On starch gel these bands exhibited pyrimidine 5'-nucleotidase activity. Two faint protein bands devoid of enzyme activity were also found in the case of polyacrylamide electrophoresis. The enzyme has a pH optimum at 7.5 and is most stable between pH 6 and 7.5. The enzyme has pI of 5.0 and a molecular weight of 28,000 by gel filtration. The Km of the purified enzyme was 10 muM, compared to 40 muM when measured in hemolysate. The higher Km in the hemolysate is due to the presence of an inhibitor. Inorganic phosphate was shown to be a competitive inhibitor of pyrimidine 5'-nucleotidase and inorganic phosphate in the hemolysate may be responsible for increasing the Km of the enzyme for the substrate cytidine monophosphate. | lld:pubmed |
| pubmed-article:20631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20631 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20631 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20631 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20631 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:20631 | pubmed:issn | 0027-8424 | lld:pubmed |
| pubmed-article:20631 | pubmed:author | pubmed-author:TorranceJ DJD | lld:pubmed |
| pubmed-article:20631 | pubmed:author | pubmed-author:BeutlerEE | lld:pubmed |
| pubmed-article:20631 | pubmed:author | pubmed-author:WhittakerDD | lld:pubmed |
| pubmed-article:20631 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20631 | pubmed:volume | 74 | lld:pubmed |
| pubmed-article:20631 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20631 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20631 | pubmed:pagination | 3701-4 | lld:pubmed |
| pubmed-article:20631 | pubmed:dateRevised | 2009-11-18 | lld:pubmed |
| pubmed-article:20631 | pubmed:meshHeading | pubmed-meshheading:20631-Hu... | lld:pubmed |
| pubmed-article:20631 | pubmed:meshHeading | pubmed-meshheading:20631-Er... | lld:pubmed |
| pubmed-article:20631 | pubmed:meshHeading | pubmed-meshheading:20631-Hy... | lld:pubmed |
| pubmed-article:20631 | pubmed:meshHeading | pubmed-meshheading:20631-He... | lld:pubmed |
| pubmed-article:20631 | pubmed:meshHeading | pubmed-meshheading:20631-Ki... | lld:pubmed |
| pubmed-article:20631 | pubmed:meshHeading | pubmed-meshheading:20631-Nu... | lld:pubmed |
| pubmed-article:20631 | pubmed:meshHeading | pubmed-meshheading:20631-Py... | lld:pubmed |
| pubmed-article:20631 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:20631 | pubmed:articleTitle | Purification and properties of human erythrocyte pyrimidine 5'-nucleotidase. | lld:pubmed |
| pubmed-article:20631 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20631 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:20631 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20631 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:20631 | lld:pubmed |
